Drug recall
Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India…
FDA recall event 99130 · Class II · Ajanta Pharma USA Inc
Key facts
| Event ID | 99130 |
|---|---|
| Recall numbers | D-0611-2026 |
| Recalling firm | Ajanta Pharma USA Inc |
| Product type | Drugs |
| Products | Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04. |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | CGMP Deviations |
| Initiation date | May 28, 2026 |
| Report date | Jul 1, 2026 |
| City | Bridgewater |
| State | NJ |
| Country | United States |
| FEI number | 3010721419 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: